![](/img/cover-not-exists.png)
Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy
Kusumoto, Shigeru, Arcaini, Luca, Hong, Xiaonan, Jin, Jie, Kim, Won Seog, Kwong, Yok Lam, Peters, Marion G., Tanaka, Yasuhito, Zelenetz, Andrew D., Kuriki, Hiroshi, Fingerle-Rowson, Günter, Nielsen, TLanguage:
english
Journal:
Blood
DOI:
10.1182/blood-2018-04-848044
Date:
October, 2018
File:
PDF, 440 KB
english, 2018